论文部分内容阅读
近年来 ,国内外均有少数医学中心将外周血干细胞移植 (ｐｅｒｉｐｈｅｒａｌｂｌｏｏｄｓｔｅｍｃｅｌｌｔｒａｎｓｐｌａｎｔａｔｉｏｎ ,ＰＢＳＣＴ)支持下的大剂量化疗 (ｈｉｇｈ ｄｏｓｅｃｈｅｍｏｔｈｅｒａｐｙ ,ＨＤＣ)应用于小细胞肺癌 ,以提高近期缓解率和远期生存率
In recent years, a small number of medical centers both at home and abroad have applied high dose chemotherapy (HDC) supported by peripheral blood stem cell transplantation (PBSCT) to small cell lung cancer to improve the recent remission rate and long-term survival rate